These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 2386512)

  • 21. [Molecular analysis of glucose-6-dehydrogenase deficiency in Spain].
    Vives Corrons JL; Zarza R; Aymerich JM; Boixadera J; Carrera A; Colomer D; Corbella M; Castro M; Crespo JM; Del Arco A; Erkiaga S; Font L; González I; Juncá J; Lausin A; Manrubia E; Martín Núñez G; Murga MJ; Oliva E; Pérez de Mendiguren B; Pujades MA; Remacha A; Rovira A; Villegas A
    Sangre (Barc); 1997 Oct; 42(5):391-8. PubMed ID: 9424740
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Chronic hemolytic anemia due to erythrocytic deficiency of glucose-60-phosphate dehydrogenase (G6PD)].
    Cutillo S
    Pediatria (Napoli); 1979 Sep; 87(3):V-VI. PubMed ID: 550112
    [No Abstract]   [Full Text] [Related]  

  • 23. Structural variants of human glucose 6-phosphate dehydrogenase (G6PD): role of intracellular decay in the expression of deficiency.
    De Flora A; Morelli A; Benatti U
    Biomed Biochim Acta; 1983; 42(11-12):S247-52. PubMed ID: 6675698
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Glucose-6-phosphate dehydrogenase deficiency. WHO Working Group.
    Bull World Health Organ; 1989; 67(6):601-11. PubMed ID: 2633878
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Hereditary glucose-6-phosphate dehydrogenase deficiency in human erythrocytes].
    Hurwic M
    Postepy Hig Med Dosw; 1970; 24(4):497-522. PubMed ID: 5458083
    [No Abstract]   [Full Text] [Related]  

  • 26. Red cell G6PD decay in circulating cells: a possible marker for variants identification.
    Pescarmona GP; Turrini F; Naitana A; Bosia A; Perroni L
    Biomed Biochim Acta; 1983; 42(11-12):S291-2. PubMed ID: 6675706
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Glucose-6-phosphate dehydrogenase in vitro correlated with in vivo activity and reticulocytosis.
    Brewster MA; Quittner H; Moriarity M
    Ann Clin Lab Sci; 1977; 7(4):325-8. PubMed ID: 20030
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Phospholipid content and phospholipid fatty acid composition of red blood cells in enzyme defect hemolytic anemias.
    Bleiber R; Eggert W; Reichmann G; Kunze D
    Acta Biol Med Ger; 1981; 40(9):1133-37. PubMed ID: 7340336
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular basis of erythroenzymopathies associated with hereditary hemolytic anemia: tabulation of mutant enzymes.
    Miwa S; Fujii H
    Am J Hematol; 1996 Feb; 51(2):122-32. PubMed ID: 8579052
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Clinical and laboratory features of erythrocyte glucosephosphate dehydrogenase deficiency].
    Jabłońska-Skwiecińska E; Traczewska M; Zelenay E
    Pediatr Pol; 1981 Sep; 56(9):1095-9. PubMed ID: 7322678
    [No Abstract]   [Full Text] [Related]  

  • 31. Mediterranean glucose 6-phosphate dehydrogenase (G6PD) deficiency--near normal decay of the mutant enzyme protein in circulating erythrocytes.
    Morelli A; Benatti U; Guida L; De Flora A
    Scand J Haematol; 1984 Aug; 33(2):144-54. PubMed ID: 6474092
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Case records of the Massachusetts General Hospital. Case 20-2013. A 29-year-old man with anemia and jaundice.
    Puig A; Dighe AS
    N Engl J Med; 2013 Jun; 368(26):2502-9. PubMed ID: 23802518
    [No Abstract]   [Full Text] [Related]  

  • 33. Pro-oxidative effects of Chinese herbal medicine on G6PD-deficient erythrocytes in vitro.
    Ko CH; Li K; Ng PC; Fung KP; Wong RP; Chui KM; Gu GJ; Yung E; Fok TF
    Toxicol In Vitro; 2008 Aug; 22(5):1222-7. PubMed ID: 18515042
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mechanisms of decreased erythrocyte deformability and survival in glucose 6-phosphate dehydrogenase mutants.
    Flynn TP; Johnson GJ; Allen DW
    Prog Clin Biol Res; 1981; 56():231-49. PubMed ID: 7330011
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Non-spherocytic congenital hemolytic anemias due to G6PD deficiency. Clinical and hematologic aspects and mechanism of hyperhemolysis].
    Sartori E; Zacchello F
    Minerva Pediatr; 1968 Dec; 20(51):2630-6. PubMed ID: 4390387
    [No Abstract]   [Full Text] [Related]  

  • 36. Brucellosis triggering hemolytic anemia in glucose-6-phosphate dehydrogenase deficiency.
    Pamuk GE; Dogan Celik A; Uyanik MS
    Med Princ Pract; 2009; 18(4):329-31. PubMed ID: 19494543
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hemolytic anemia and G6PD deficiency.
    Yoshida A
    Science; 1973 Feb; 179(4073):532-7. PubMed ID: 4405605
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Discussion on pharmacogenetic interaction in G6PD deficiency and methods to identify potential hemolytic drugs.
    Manganelli G; Fico A; Martini G; Filosa S
    Cardiovasc Hematol Disord Drug Targets; 2010 Jun; 10(2):143-50. PubMed ID: 20350285
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Metabolism of the hexose monophosphate shunt in glucose-6-phosphate dehydrogenase deficiency and closely interrelated reactions.
    Jacobasch G; Bleiber R; Schönian G
    Haematologia (Budap); 1982 Dec; 15(4):401-7. PubMed ID: 7186479
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Red cell glucose-6-phosphate dehydrogenase deficiency in Finland. Further biochemical characterization of G-6-PD Helsinki.
    Härkönen M; Vuopio P
    Ann Clin Res; 1974 Aug; 6(4):187-97. PubMed ID: 4154719
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.